Clinicopathological analyses in patients with other iatrogenic immunodeficiency-associated lymphoproliferative diseases and rheumatoid arthritis

References

• Gaulard P SS, Harris NL, Jaffe ES, . Other iatrogenic immunodeficiency-associated lymphoproliferative disorders. In: Swerdlow SH CE, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues Vol., 4th edn. IARC: Lyon; 2008. pp. 350–351.
   Google Scholar
• Kamel OW, van de Rijn M, Weiss LM, . Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. New England Journal of Medicine 1993;328:1317–1321.
   PubMed Web of Science ®Google Scholar
• Hoshida Y, Tomita Y, Zhiming D, . Lymphoproliferative disorders in autoimmune diseases in Japan: analysis of clinicopathological features and Epstein-Barr virus infection. International Journal of Cancer 2004;108:443–449.
   PubMed Web of Science ®Google Scholar
• Kamel OW, van de Rijn M, Hanasono MM, . Immunosuppression-associated lymphoproliferative disorders in rheumatic patients. Leukemia & Lymphoma 1995;16:363–368.
   PubMed Web of Science ®Google Scholar
• Hoshida Y, Xu JX, Fujita S, . Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication. Journal of Rheumatology 2007;34:322–331.
   PubMed Web of Science ®Google Scholar
• Weinblatt ME, Coblyn JS, Fox DA, . Efficacy of low-dose methotrexate in rheumatoid arthritis. New England Journal of Medicine 1985;312:818–822.
   PubMed Web of Science ®Google Scholar
• Swierkot J, Szechiński J. Methotrexate in rheumatoid arthritis. Pharmacological Report 2006;58:473–492.
   PubMed Web of Science ®Google Scholar
• Adams AE, Zwicker J, Curiel C, . Aggressive cutaneous T-cell lymphomas after TNFalpha blockade. Journal of American Academy of Dermatology 2004;51:660–662.
   PubMed Web of Science ®Google Scholar
• Diak P, Siegel J, La Grenade L, . Tumor necrosis factor alpha blockers and malignancy in children: forty-eight cases reported to the Food and Drug Administration. Arthritis & Rheumatism 2010;62:2517–2524.
   PubMed Web of Science ®Google Scholar
• Rizzi R, Curci P, Delia M, . Spontaneous remission of “methotrexate-associated lymphoproliferative disorders” after discontinuation of immunosuppressive treatment for autoimmune disease. Review of the literature. Medical Oncology 2009;26:1–9.
   PubMed Web of Science ®Google Scholar
• Miyazaki T, Fujimaki K, Shirasugi Y, . Remission of lymphoma after withdrawal of methotrexate in rheumatoid arthritis: relationship with type of latent Epstein-Barr virus infection. American Journal of Hematology 2007;82:1106–1109.
   PubMed Web of Science ®Google Scholar
• Baird RD, van Zyl-Smit RN, Dilke T, . Spontaneous remission of low-grade B-cell non-Hodgkin's lymphoma following withdrawal of methotrexate in a patient with rheumatoid arthritis: case report and review of the literature. British Journal of Haematology 2002;118:567–568.
   PubMed Web of Science ®Google Scholar
• Salloum E, Cooper DL, Howe G, . Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. Journal Clinical Oncology 1996;14:1943–1949.
   PubMed Web of Science ®Google Scholar
• Parada LA, Hallén M, Tranberg KG, . Frequent rearrangements of chromosomes 1, 7, and 8 in primary liver cancer. Genes, Chromosomes and Cancer 1998;23:26–35.
   PubMed Web of Science ®Google Scholar
• Sawyer JR, Tricot G, Mattox S, . Jumping translocations of chromosome 1q in multiple myeloma: evidence for a mechanism involving decondensation of pericentromeric heterochromatin. Blood 1998;91:1732–1741.
   PubMed Web of Science ®Google Scholar
• Hasserjian RP, Chen S, Perkins SL, Immunomodulator agent-related lymphoproliferative disorders. Modern Pathology 2009;22:1532–1540.
   PubMed Web of Science ®Google Scholar
• Alspaugh MA, Henle G, Lennette ET, . Elevated levels of antibodies to Epstein-Barr virus antigens in sera and synovial fluids of patients with rheumatoid arthritis. Journal of Clinical Investigation 1981;67:1134–1140.
   PubMed Web of Science ®Google Scholar
• Sawada S, Takei M. Epstein-Barr virus etiology in rheumatoid synovitis. Autoimmunity Reviews 2003;4:106–110.
   Web of Science ®Google Scholar
• Balandraud N, Meynard JB, Auger I, . Epstein-Barr virus load in the peripheral blood of patients with rheumatoid arthritis: accurate quantification using real-time polymerase chain reaction. Arthritis & Rheumatism 2003;48:1223–1228.
   PubMed Web of Science ®Google Scholar
• Mariette X, Cazals-Hatem D, Warszawki J, . Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France. Blood 2002;99:3909–3915.
   PubMed Web of Science ®Google Scholar
• Niitsu N, Okamoto M, Nakamine H, . Clinicopathologic correlations of diffuse large B-cell lymphoma in rheumatoid arthritis patients treated with methotrexate. Cancer Science 2010; 101:1309–1313.
   PubMed Web of Science ®Google Scholar
• Moder KG, Tefferi A, Cohen MD, . Hematologic malignancies and the use of methotrexate in rheumatoid arthritis: a retrospective study. American Journal of Medicine 1995;99:276–281.
   PubMed Web of Science ®Google Scholar
• Baecklund E, Backlin C, Iliadou A, . Characteristics of diffuse large B cell lymphomas in rheumatoid arthritis. Arthritis & Rheumatism 2006;54:3774–3781.
   PubMed Web of Science ®Google Scholar
• Balandraud N, Meynard JB, Auger I, . Epstein-Barr virus load in the peripheral blood of patients with rheumatoid arthritis: accurate quantification using real-time polymerase chain reaction. Arthritis & Rheumatism 2003;48:1223–1228.
   PubMed Web of Science ®Google Scholar
• Lioté F, Pertuiset E, Cochand-Priollet B, . Methotrexate related B lymphoproliferative disease in a patient with rheumatoid arthritis. Role of Epstein-Barr virus infection. Journal of Rheumatology 1995;22:1174–1178.
   PubMed Web of Science ®Google Scholar